L&C BIO Co.,LTD (KOSDAQ:290650)

South Korea flag South Korea · Delayed Price · Currency is KRW
30,400
-50 (-0.16%)
Jun 13, 2025, 3:30 PM KST
40.42%
Market Cap 748.41B
Revenue (ttm) 73.32B
Net Income (ttm) 139.08B
Shares Out 24.62M
EPS (ttm) 5,558.47
PE Ratio 5.40
Forward PE n/a
Dividend 50.00 (0.16%)
Ex-Dividend Date Dec 27, 2024
Volume 437,551
Average Volume 490,759
Open 30,650
Previous Close 30,450
Day's Range 28,850 - 30,900
52-Week Range 15,000 - 33,250
Beta 0.71
RSI 63.98
Earnings Date Aug 12, 2025

About L&C BIO Co.,LTD

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. It offers human tissue, medical device, and cosmetics products. The company was founded in 2011 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2011
Employees 132
Stock Exchange KOSDAQ
Ticker Symbol 290650
Full Company Profile

Financial Performance

In 2024, L&C BIO Co.,LTD's revenue was 72.09 billion, an increase of 9.35% compared to the previous year's 65.93 billion. Earnings were 141.06 billion, an increase of 191.69%.

Financial Statements

News

There is no news available yet.